Skip to main content
. 2024 Mar 12;13(6):1617. doi: 10.3390/jcm13061617
T2D type 2 diabetes
CV cardiovascular
GLP-1ra glucagon-like peptide 1 receptor agonists
SGLT-2in sodium-glucose cotransporter-2 inhibitors
CVD cardiovascular disease
ADA American Diabetes Association
EASD European Association for the Study of Diabetes
HbA1c hemoglobin A1c
LDL low-density lipoprotein
HDL high-density lipoprotein
CAD coronary artery disease
ASCVD atherosclerotic cardiovascular disease
CVOT’s cardiovascular outcome trials
CHF chronic heart failure
CKD chronic kidney disease
AI Artificial Intelligence
DKA diabetic ketoacidosis
PS propensity score